SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Tech Stock Options

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gersh Avery who wrote (42138)5/4/1998 2:10:00 PM
From: ViperChick Secret Agent 006.9  Read Replies (1) of 58727
 
ceo on cnbc..entremed

Dr John Holaday

starve tumors to death by keeping nutrients from them

cautious about using the word "cure"
long way from "mouse to man"

new way of looking at disease will make a difference

Joe K says
alot of other companies are saying they have an angio type thing...

Entremeds works on normal cells...

they think they have honed in on the most important...
oh sheesh..you got to find an article

there is too much lingo here....we need to find Nancy the "drug queen"

they have done more with mouse tumors than other companies..

only 1 1/2 years into this....

avg is 6 -7 years....of getting drug through...of course they hope to be able to do it faster
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext